We found that DMBT1 rs2981804 genotypes might be associated with albumin concentrations at diagnosis (IBD, UC), event of perforation (CD), frequency, number of agents and time to first biological treatment (IBD, UC, CD) (including infliximab (IBD)), frequency of cutaneous manifestations (CD) and the presence of concomitant diseases (IBD, CD) and severe behaviour of the UC disease. Here, ALB is linked to inflammatory bowel disease.